Figure 1.

Distributions of various guideline‐directed medications and therapies, stratified by black and white patients hospitalized with non–ST‐segment–elevation myocardial infarction. ACEi indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker.